Does RIFABUTIN Cause Hypertransaminasaemia? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Hypertransaminasaemia have been filed in association with RIFABUTIN (Rifabutin). This represents 1.5% of all adverse event reports for RIFABUTIN.
23
Reports of Hypertransaminasaemia with RIFABUTIN
1.5%
of all RIFABUTIN reports
1
Deaths
19
Hospitalizations
How Dangerous Is Hypertransaminasaemia From RIFABUTIN?
Of the 23 reports, 1 (4.3%) resulted in death, 19 (82.6%) required hospitalization.
Is Hypertransaminasaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIFABUTIN. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does RIFABUTIN Cause?
Drug ineffective (171)
Off label use (127)
Drug resistance (123)
Drug interaction (99)
Drug intolerance (97)
Pyrexia (95)
Drug reaction with eosinophilia and systemic symptoms (81)
Nausea (77)
Neutropenia (77)
Mycobacterium avium complex infection (76)
What Other Drugs Cause Hypertransaminasaemia?
METHOTREXATE (436)
ACETAMINOPHEN (326)
PACLITAXEL (318)
CARBOPLATIN (304)
PEMBROLIZUMAB (231)
ATORVASTATIN (207)
CYCLOPHOSPHAMIDE (202)
PREDNISONE (198)
GEMCITABINE (196)
DEXAMETHASONE (169)
Which RIFABUTIN Alternatives Have Lower Hypertransaminasaemia Risk?
RIFABUTIN vs RIFAMPICIN
RIFABUTIN vs RIFAMPIN
RIFABUTIN vs RIFAMYCIN
RIFABUTIN vs RIFAPENTINE
RIFABUTIN vs RIFAXIMIN